Always consult a healthcare professional before starting or stopping any medication
Currently, there is an ongoing randomised double-masked placebo-controlled trial, the SUMMIT trial, studying the efficacy and safety of tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide and GLP-1 receptors, versus placebo in HFpEF patients with obesity (NCT04847557)
A thoughtful GLP-1 diet is not about eating less just for the sake of it
While changes in appearance alone might not be a cause for concern, its important to monitor for symptoms like urinary leakage, pelvic heaviness, bulging, or painful vaginal dryness
The abdomen: the most popular GLP-1 injection site for weight loss Ask experienced GLP-1 users where they prefer to inject, and the majority will point to their stomach
These drugs, originally developed to manage diabetes, have gained significant attention for their weight loss benefits